Febrile non-hemolytic transfusion reaction (FNHTR) is the most common adverse effect of blood transfusion. FNHTR is usually immune mediated due to the reaction of white cells antibodies in the recipient's plasma with the leukocytes contanied in the transfused blood components. In some patients, especially recipients transfused with platelets, cytokines are implicated in this reaction. The differential diagnosis may be difficult, especially when co-morbid disorders such as infection or malignancy, and certain treatments, may cause a similar spectrum of symptoms. In differential diagnosis, acute haemolytic transfusion reaction, bacterialy contaminated blood products and transfusion associated lung injury must be exlcuded. Repeated severe FNHTRs necessitate leucocyte depletion of blood components.
B. J, B L. Grgićević D.: Hematologija i transfuziologija. Zagreb: Jugosl medicinska naklada.
2.
J.A.F N. Handbook of Blood Transfusion Therapy.
3.
Matthien F. A Very Simple and Nonexpensive Technique to Prevent Febrile Nonhemolytic Transfusion Reactions in HLA-Immunized Patients. Vox Sang. 68:201–2.
4.
T. SI, C. U, S. M. Adsorption of anaphylatoxins and platelet specific proteins by filtration of platelet concentrates with a polyester leukocyte reduction filter. Vox Sang. 66:161–5.
5.
I. A, A. P, C. S. Influence of the red blood cell preparation method on the efficiency of a leukocyte reduction filter. Vox Sang. 71:78–83.
6.
P. R, W.H D. Multicenter evaluation of methods for counting residual white cells in leukocyte-depleted red blood cells. Vox Sang. 66:25–32.
7.
A. F, Y T. Romeo A.: Relative efficiency of leukocyte removal procedures for the production of leukocyte-poor red cell concentrates assessed by flow cytometry. Vox Sang. 66:153–60.
8.
D. V, B B. Ilić V. i sar.: Imunomodulatorni efekti transfuzija alogene krvi. Vojno sanitetski pregled. 54:51–9.
9.
C.F H. Labile blood components.
10.
B. B, M. R, L B. Andrić Z.: Citokini modiferi hemobiološkog odgovora. Bilten za transfuziju. 40:13–25.
11.
Mitrović S. Nepovoljni efekti transfuzije trombocita. Bilten za transfuziju. 22(2):54–8.
12.
Radović M. Nepovoljni efekti hemoterapije. Anestezija, Reanimacija i Transfuzija.
13.
D. S, J S. Wells V.: Osnovna i klinička imunologija.
14.
Anderson K. Ness P.: Scientific Basis of Transfusion Medicine.
15.
V. G, B. B, transfuziologija K. Beograd: Zavod za udžbenike i nastavna sredstva.
16.
A. A, A L. Pober J.: Cellular and Molecular Immunology.
17.
N. H, M. T, L. K, J S. Factors affecting cytokine production in platelet concentrates. Transfusion. 35:200–5.
18.
C.B. SA, J.M. K, R. S. The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion. 38(3):229–35.
19.
F. F, P.L. T, D. M. White cell apoptosis in platelet concentrates. Transfusion. 40(2):160–8.
20.
N.M H. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol. 6(6):420–6.
21.
E.L S. The role of cytokines and adhesive molecules in febrile non-hemolytic transfusion reactions. Immunol Invest. 24(1–2):333–9.
22.
D. R, E. R, P. R. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coat. Transfusion. 37(5):528–30.
23.
L. M, M.E P. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang. 66(1):7–14.
24.
W.H D. Is the febrile response to transfusion due to donor or recipient cytokine? Transfusion. 32(594).
25.
N.M H. Febrile non-haemolytic transfusion reactions to platelets. Curr Opin Hematol. 2:478–83.
26.
D.B B. Clinical significance of white cell antibodies in febrile nonhaemolytic transfusion reactions. Transfusion. 30:733–7.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
